SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imaging Diagnostics Systems - IMDS

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe Bob who wrote (1)4/2/1998 2:55:00 PM
From: Scott Phillips  Read Replies (1) of 9
 
The Hawke Group, Inc. is a Financial Public Relations Firm who represents Imaging Diagnostics Systems, Inc. (IDSI).
As with most medical technology companies, the R&D costs to develop their product may shelter early income. However, the company projects revenues of 65.9 mm for the fiscal year ending 6-30-99 with pre-tax income of $32 mm. At current, outstanding share levels of 29.4 mm, this equates to projected earnings of $1.08 per share. While these are projections and actual results could differ - this gives you an idea of the profit potential this company has.

IDSI hopes to have machines in place for their expanded trails by the end of April or beginning of May. A shareholder letter is being prepared at this time and should go out within a week or so. The locations of the test locations have not been announced yet and can not be disclosed until the equipment is in place and testing is ready to begin.

If you would like to be kept updated on IDSI please contact us at 954-564-7114 or fill out the feedback page at www.hawkegroup.com and we will send you whatever information you need.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext